US Patent Issued to Takeda Pharmaceutical on Feb. 17 for "Determination of modification degree of therapeutic proteins using 1H-NMR spectroscopy" (Austrian Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,842, issued on Feb. 17, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Determination of modification degree of therapeutic proteins using 1H-NMR spectroscopy" was invented by Jean-Baptiste Farcet (Vienna) and Juergen Siekmann (Vienna).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides, among other things, methods for determining the average number of first polymers covalently attached to protein-first polymer conjugates in a solution."

The patent was filed on Feb. 24, 2021, under Application No. 17/904,153.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacg...